| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 511,8 k € | +13.7% | 450,2 k € | +9.2% | 412,1 k € | +2.3% | 403,0 k € | +6.2% | 379,4 k € | +9.4% | 346,8 k € | +79.9% | 192,7 k € | -8.0% | 209,6 k € | +3.9% | 201,7 k € | +3.6% | 194,6 k € | +28.8% | 151,1 k € | -18.8% | 186,1 k € | -4.5% | 194,9 k € | -2.1% | 199,1 k € | -1.4% | 202,0 k € | -4.5% | 211,4 k € | -13.9% | 245,5 k € | +10.0% | 223,1 k € | |
| EBITDA | 439,6 k € | +22.7% | 358,4 k € | +2.4% | 350,1 k € | +0.6% | 348,1 k € | +5.6% | 329,8 k € | +9.2% | 302,1 k € | +107.0% | 146,0 k € | -10.6% | 163,2 k € | +4.8% | 155,8 k € | +3.3% | 150,9 k € | +34.9% | 111,8 k € | -16.9% | 134,6 k € | -1.0% | 136,0 k € | -5.6% | 144,0 k € | -12.6% | 164,8 k € | -5.2% | 173,9 k € | -17.1% | 209,7 k € | +11.0% | 188,9 k € | |
| Operating profit | 365,3 k € | +25.3% | 291,6 k € | +4.0% | 280,5 k € | +8.5% | 258,5 k € | +4.9% | 246,5 k € | +5.0% | 234,8 k € | +134.4% | 100,2 k € | -23.9% | 131,7 k € | +8.9% | 120,9 k € | +4.8% | 115,4 k € | +63.6% | 70,5 k € | +3.0% | 68,4 k € | -1.6% | 69,5 k € | -9.6% | 76,9 k € | -28.9% | 108,2 k € | -6.3% | 115,5 k € | -29.6% | 164,2 k € | +36.8% | 120,1 k € | |
| Profit/loss | 249,9 k € | +25.9% | 198,5 k € | +6.5% | 186,4 k € | +6.9% | 174,4 k € | -2.9% | 179,6 k € | +4.9% | 171,2 k € | +156.3% | 66,8 k € | -22.8% | 86,5 k € | +0.9% | 85,7 k € | -3.5% | 88,9 k € | +42.8% | 62,2 k € | -1.5% | 63,2 k € | -9.7% | 70,0 k € | +1.2% | 69,2 k € | -28.5% | 96,7 k € | +7.5% | 89,9 k € | -25.7% | 121,0 k € | +40.8% | 85,9 k € | |
| Equity | 1,8 M € | +15.8% | 1,6 M € | +14.4% | 1,4 M € | +15.6% | 1,2 M € | +17.1% | 1,0 M € | +21.4% | 839,2 k € | +25.6% | 668,0 k € | +11.1% | 601,2 k € | +16.8% | 514,7 k € | -55.0% | 1,1 M € | +8.4% | 1,1 M € | +6.3% | 992,2 k € | +6.8% | 929,0 k € | -16.2% | 1,1 M € | +6.7% | 1,0 M € | +10.2% | 943,2 k € | +10.5% | 853,2 k € | +16.5% | 732,3 k € | |
| Total assets | 1,9 M € | +9.9% | 1,7 M € | +13.8% | 1,5 M € | +18.1% | 1,3 M € | +11.6% | 1,2 M € | +26.1% | 915,3 k € | +25.9% | 727,1 k € | +9.5% | 664,0 k € | -49.3% | 1,3 M € | +7.6% | 1,2 M € | +12.7% | 1,1 M € | +4.9% | 1,0 M € | -17.3% | 1,2 M € | +4.3% | 1,2 M € | +5.4% | 1,1 M € | +5.2% | 1,1 M € | +5.5% | 1,0 M € | +14.8% | 888,5 k € | |
| Cash | 1,1 M € | +28.8% | 853,8 k € | -27.8% | 1,2 M € | +33.6% | 885,0 k € | +33.5% | 663,1 k € | +26.2% | 525,5 k € | +48.7% | 353,4 k € | +12.9% | 313,0 k € | -66.4% | 932,5 k € | +11.9% | 833,5 k € | +17.8% | 707,5 k € | +15.0% | 615,4 k € | -19.2% | 762,0 k € | +14.9% | 663,0 k € | +12.0% | 591,9 k € | +18.7% | 498,8 k € | +11.7% | 446,5 k € | +67.4% | 266,8 k € | |
| Debts | 73,1 k € | -51.7% | 151,5 k € | +7.7% | 140,7 k € | +50.5% | 93,5 k € | -30.2% | 133,9 k € | +78.7% | 74,9 k € | +38.7% | 54,0 k € | -12.2% | 61,5 k € | -92.2% | 793,5 k € | +1006.4% | 71,7 k € | +188.2% | 24,9 k € | -30.9% | 36,0 k € | -88.5% | 314,5 k € | +276.9% | 83,4 k € | -8.3% | 91,0 k € | -30.8% | 131,5 k € | -20.4% | 165,2 k € | +5.7% | 156,2 k € | |
| Staff | — | — | — | 0,5 | 0,7 | 0,5 | 0,9 | 0,5 | 0,5 | 0,5 | 0,5 | 1,3 | 1,5 | 1,3 | 0,5 | 0,5 | 0,5 | 0,5 | ||||||||||||||||||
Private limited company · Meise · incorporated on 15/05/1996
Private limited company profitable and well capitalised. Cash position rising (+28.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. J.R. SCHOYSMAN is a Private limited company incorporated in 1996. Its main activity is: Other human health activities. Its registered office is in Meise.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette